Comparative in-vitro activity of LY146032 and eight other antibiotics against gram-positive bacteria isolated from children

Pharmacology, Toxicology and Pharmaceutical Science

• Antibiotics 100%
• Vancomycin 100%
• Gram Positive Bacterium 100%
• Daptomycin 100%
• Meticillin 75%
• Chloramphenicol 50%
• Gentamicin 50%
• Streptococcus Group D 50%
• Staphylococcus aureus 25%
• Clindamycin 25%
• Enterococcus 25%
• Staphylococcal Infection 25%
• Ampicillin 25%
• Penicillin 25%
• Polypeptide Antibiotic Agent 25%
• Streptococcus 25%
• Listeria monocytogenes 25%
• Cefuroxime 25%
• Cyclopeptide 25%
• Group B Streptococcal Pneumonia 25%

Keyphrases

• Antibiotics 100%
• In Vitro Activity 100%
• Gram-positive Bacteria 100%
• Staph 100%
• Staphylococcus Epidermidis (S. epidermidis) 50%
• Vancomycin 50%
• Aureus 50%
• Methicillin Resistance 25%
• Chloramphenicol 25%
• Gentamicin 25%
• Listeria Monocytogenes 25%
• Group D Streptococcus 25%
• Hospital-acquired 12%
• Staphylococcus Aureus 12%
• Staphylococcal Infections 12%
• Enterococcus 12%
• Clindamycin 12%
• Community-acquired 12%
• Streptococcus Pneumoniae 12%
• Penicillin 12%
• Cefepime 12%
• Methicillin 12%
• Group B Streptococcus 12%
• Gram-positive 12%
• Ampicillin 12%
• Susceptible Strain 12%
• Cyclic Peptide 12%
• Peptide Antibiotics 12%

Immunology and Microbiology

• Gram-Positive Bacteria 100%
• In Vitro 100%
• Streptococcus Group D 66%
• Staphylococcus aureus 33%
• Streptococcus pneumonia 33%
• Penicillin 33%
• Streptococcus 33%
• Listeria monocytogenes 33%
• Enterococcus 33%
• Cyclic Peptide 33%
• Infection 33%